22 min listen
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy
ratings:
Length:
36 minutes
Released:
Oct 21, 2020
Format:
Podcast episode
Description
For this special edition of Oncology Today, I met with Dr Courtney DiNardo from the MD Anderson Cancer Center in Houston, Texas, to discuss recently published and emerging research on the management of acute myeloid leukemia not eligible for intensive induction therapy.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAMLIntensiveTx20).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAMLIntensiveTx20).
Released:
Oct 21, 2020
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love